HU Group Holdings News and Activities

Presence

HU Group Holdings provides clinical testing and healthcare support services. Its main products and services include laboratory testing, diagnostic reagents, and related systems for hospitals, clinics, and healthcare organizations.

HU Group Holdings products and services overview:

Laboratory testing
Diagnostic reagents
Medical devices
Healthcare systems
Drug development support
Home healthcare

Revenue: ~$1 billion

Employees: 13,000

Headquarters: Tokyo, Japan

HU Group Holdings is one of the...

HU Group Holdings is a company listed under the stock ticker 4544 (JP).

HU Group Holdings has a direct presence in 4 countries.

HU Group Holdings has 5 subsidiaries including Fujirebio, Fujirebio Diagnostics and Fujirebio Diagnostics Europe.

They are in:

Executives

View the org chart displaying its 46 main executives

Most searched biographies at HU Group Holdings

Popular executive movements at HU Group Holdings

Shigekazu Takeuchi, Representative Executive Officer, Vice President and Director, is retiring (posted on January 14 2026).
Goki Ishikawa, who was Chief Executive Office, In Vitro Diagnostics, is promoted to President and Chief Executive Officer (posted on January 14 2026).

Create your alert
to follow the executive moves at HU Group Holdings.